9.7 C
Glasgow
Wednesday, December 10, 2025
spot_img
Homebiotech

biotech

Stay Connected
- Advertisement -spot_img
Latest Articles

Potent and selective antitumour activity in acute myeloid leukaemia study

Orum Therapeutics, a public biotechnology company working on degrader-antibody conjugates (DACs), has presented preclinical data for ORM-1153 at the 67th American Society of Hematology...